A 66-year-old man presented with a white blood cell count of 62.6 3 10 9 /L. Peripheral blood (PB) smear showed 80% small-to medium-sized atypical lymphoid cells with irregular to cleaved (panel A; original magnification 3500, Wright-Giemsa stain) or binucleated nuclear contours, and slightly condensed chromatin (panel B; original magnification 31000, Wright-Giemsa stain). Bone marrow (BM) aspirate (panel C; original magnification 3500, Wright-Giemsa stain) and biopsy (panel D; original magnification 3400, hematoxylin and eosin stain) showed ;70% atypical lymphoid cells with similar features to those of PB. These lymphoid cells were positive for CD20 (panel E; original magnification 3200) and CD5 (panel F; original magnification 3100), negative for CD3 (panel G; original magnification 3100) and cyclin D1 (not shown), but showed strong nuclear immunoreactivity for SOX11 (panel H; original magnification 3400) and ;70% proliferation index by Ki-67 (panel I; original magnification 3200). Flow cytometry of PB and BM showed l-restricted monotypic B cells, positive for FMC-7 but negative for CD23. Conventional karyotyping showed 46,XY [20], and fluorescence in situ hybridization analysis of BM showed no cyclin D1 or MYC rearrangements. A diagnosis of cyclin D1-negative blastoid mantle cell lymphoma (BMCL) was established. This is an unusual BMCL with the following 3 features: initial leukemic presentation; markedly irregular to binucleated nuclear contours, which can be confused with other lymphomas such as follicular lymphoma or adult T-cell leukemia/lymphoma; and lack of cyclin D1 at both the protein and genetic level. Next-generation sequencing revealed KMT2D and TP53 mutations but no rearrangement of cyclin D2 or D3, respectively. Cyclin D1-negative MCL is difficult to recognize, but strong SOX11 nuclear immunoreactivity is helpful in this regard.
D E F G H I
c Huan-You Wang and Alexey Hodkoff, University of California San Diego A 66-year-old man presented with a white blood cell count of 62.6 3 10 9 /L. Peripheral blood (PB) smear showed 80% small-to medium-sized atypical lymphoid cells with irregular to cleaved (panel A; original magnification 3500, Wright-Giemsa stain) or binucleated nuclear contours, and slightly condensed chromatin (panel B; original magnification 31000, Wright-Giemsa stain). Bone marrow (BM) aspirate (panel C; original magnification 3500, Wright-Giemsa stain) and biopsy (panel D; original magnification 3400, hematoxylin and eosin stain) showed ;70% atypical lymphoid cells with similar features to those of PB. These lymphoid cells were positive for CD20 (panel E; original magnification 3200) and CD5 (panel F; original magnification 3100), negative for CD3 (panel G; original magnification 3100) and cyclin D1 (not shown), but showed strong nuclear immunoreactivity for SOX11 (panel H; original magnification 3400) and ;70% proliferation index by Ki-67 (panel I; original magnification 3200). Flow cytometry of PB and BM showed l-restricted monotypic B cells, positive for FMC-7 but negative for CD23. Conventional karyotyping showed 46,XY [20] , and fluorescence in situ hybridization analysis of BM showed no cyclin D1 or MYC rearrangements. A diagnosis of cyclin D1-negative blastoid mantle cell lymphoma (BMCL) was established. This is an unusual BMCL with the following 3 features: initial leukemic presentation; markedly irregular to binucleated nuclear contours, which can be confused with other lymphomas such as follicular lymphoma or adult T-cell leukemia/lymphoma; and lack of cyclin D1 at both the protein and genetic level. Next-generation sequencing revealed KMT2D and TP53 mutations but no rearrangement of cyclin D2 or D3, respectively. Cyclin D1-negative MCL is difficult to recognize, but strong SOX11 nuclear immunoreactivity is helpful in this regard.
